The Chemours Company (NYSE:CC) Receives $18.00 Average Target Price from Analysts

Shares of The Chemours Company (NYSE:CCGet Free Report) have received a consensus rating of “Hold” from the twelve analysts that are presently covering the company, Marketbeat reports. Two analysts have rated the stock with a sell rating, five have assigned a hold rating and five have issued a buy rating on the company. The average 1-year target price among analysts that have updated their coverage on the stock in the last year is $18.00.

CC has been the topic of a number of research reports. Royal Bank Of Canada reissued an “outperform” rating and issued a $18.00 price objective on shares of Chemours in a research note on Friday, January 16th. The Goldman Sachs Group raised their price objective on shares of Chemours from $14.00 to $18.00 and gave the stock a “neutral” rating in a research note on Wednesday, February 25th. Truist Financial upped their target price on Chemours from $18.00 to $21.00 and gave the company a “buy” rating in a report on Wednesday, January 21st. Morgan Stanley increased their price objective on Chemours from $15.00 to $17.00 and gave the stock an “equal weight” rating in a report on Monday, February 23rd. Finally, JPMorgan Chase & Co. lifted their target price on shares of Chemours from $13.00 to $17.00 and gave the company a “neutral” rating in a research note on Monday, February 23rd.

Get Our Latest Stock Report on CC

Institutional Trading of Chemours

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Atlas Capital Advisors Inc. bought a new stake in shares of Chemours in the fourth quarter valued at approximately $26,000. MTM Investment Management LLC bought a new stake in Chemours in the 2nd quarter valued at $27,000. Aster Capital Management DIFC Ltd bought a new stake in Chemours in the 4th quarter valued at $28,000. Covestor Ltd grew its position in Chemours by 204.7% in the 4th quarter. Covestor Ltd now owns 2,602 shares of the specialty chemicals company’s stock worth $31,000 after purchasing an additional 1,748 shares during the last quarter. Finally, Eurizon Capital SGR S.p.A. bought a new position in shares of Chemours during the 4th quarter worth about $31,000. Institutional investors and hedge funds own 76.26% of the company’s stock.

Chemours Stock Performance

Shares of NYSE CC opened at $18.27 on Friday. Chemours has a 12-month low of $9.13 and a 12-month high of $21.85. The company has a market cap of $2.74 billion, a PE ratio of -7.36 and a beta of 1.60. The stock has a 50 day simple moving average of $15.86 and a 200-day simple moving average of $14.66. The company has a current ratio of 1.78, a quick ratio of 0.85 and a debt-to-equity ratio of 16.33.

Chemours (NYSE:CCGet Free Report) last issued its quarterly earnings data on Thursday, February 19th. The specialty chemicals company reported $0.05 earnings per share for the quarter, beating analysts’ consensus estimates of $0.01 by $0.04. The business had revenue of $1.33 billion for the quarter, compared to analysts’ expectations of $1.33 billion. Chemours had a negative net margin of 6.41% and a positive return on equity of 41.75%. The company’s revenue was down 2.2% on a year-over-year basis. During the same period in the previous year, the business earned $0.09 earnings per share. On average, equities research analysts forecast that Chemours will post 2.03 EPS for the current year.

Chemours Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 13th. Stockholders of record on Friday, February 27th will be paid a $0.0875 dividend. This represents a $0.35 dividend on an annualized basis and a dividend yield of 1.9%. The ex-dividend date is Friday, February 27th. Chemours’s payout ratio is presently -14.11%.

About Chemours

(Get Free Report)

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.

Read More

Analyst Recommendations for Chemours (NYSE:CC)

Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.